Fulminant Myocarditis

Latest news

Tag

Unraveling sST2’s Role in Fulminant Myocarditis: A Novel Mitochondrial Therapeutic Axis

Elevated soluble ST2 worsens fulminant myocarditis by impairing cardiomyocyte mitochondria via IGF2R-YY1, providing a new prognostic biomarker and therapeutic target.

Oct 25, 2026

Cardiology

Repurposing Hydroxychloroquine for Chronic Inflammatory Cardiomyopathy: Evidence from the HYPIC Multicenter Randomized Trial

The HYPIC trial demonstrates that hydroxychloroquine combined with prednisolone significantly improves cardiovascular outcomes, cardiac function, and cytokine profiles in patients with chronic inflammatory cardiomyopathy following fulminant

Dec 28, 2025